If this comes through it will be a leader in the prevention of subsequent heart attack treatment market. To my understanding no one else has used plasma based treatment and obviously CSL huge infrastructure in this industry. It is going to be an interesting wait together with Vifor merging benefits broker recommendations around $340 looks feasible.
Ann: CSL European Investor Site Tour Presentations, page-6
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$282.00 |
Change
0.660(0.23%) |
Mkt cap ! $136.2B | |||
| Open | High | Low | Value | Volume |
| $283.00 | $284.64 | $281.65 | $164.0M | 579.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3 | $282.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $282.02 | 469 | 2 |
View Market Depth
| Last trade - 16.10pm 04/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$282.49 |
Change
0.660 ( 0.53 %) |
||||
| Open | High | Low | Volume | ||
| $283.00 | $284.55 | $281.72 | 36821 | ||
| Last updated 15.59pm 04/06/2024 ? | |||||
| CSL (ASX) Chart |